Defunct Company
Total Trials
199
As Lead Sponsor
183
As Collaborator
16
Total Enrollment
62,267
NCT01491204
Clinical Trial to Determine the Maximum Tolerated Dose and to Assess the Safety and Pharmacokinetic Profile of Oral Paclitaxel in Patients With Advanced Solid Cancer
Phase: Phase 1
Role: Lead Sponsor
Start: Aug 31, 2006
Completion: Oct 31, 2008
NCT00942344
Efficacy and Safety of Amlodipine and Losartan in Patients With Essential Hypertension
Phase: Phase 2
Start: May 31, 2007
Completion: Dec 31, 2007
NCT01830517
Diurnal Variation in Hypertensive Stroke Patients
Phase: Phase 4
Start: Aug 31, 2007
Completion: Feb 29, 2012
NCT00973115
Efficacy and Safety of Morning Versus Evening Intake of Simvast Controlled Release (CR) Tablet in Patients With Hyperlipidemia
Phase: Phase 3
Start: Nov 30, 2007
Completion: Aug 31, 2009
NCT00940680
Efficacy/Safety of Amlodipine Plus Losartan Versus Losartan in Patients With Essential Hypertension
Start: Apr 30, 2008
Completion: Nov 30, 2008
NCT00940667
Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Essential Hypertension
Start: May 31, 2008
Completion: Dec 31, 2008
NCT00986843
Clinical Trial to Evaluate Safety and Tolerability of OratecanTM in Patients With Advanced Solid Malignancies (Oratecan-102)
Start: Jun 30, 2008
Completion: Sep 30, 2012
NCT00979563
Clinical Trial to Evaluate Safety and Tolerability of OratecanTM in Patients With Advanced Solid Malignancies
Start: Jul 31, 2008
Completion: Nov 30, 2010
NCT01830491
Comparison of Effect & Safety of Clopidogrel Napadisilate With Clopidogrel Bisulfate in Coronary Artery Disease Patients
Start: Mar 31, 2009
Completion: Dec 31, 2009
NCT01127217
Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Stage 2 Hypertension
Start: May 31, 2009
Completion: Mar 31, 2010
NCT01491217
A Study of Oraxol® in Gastric Cancer Patients
Phase: Phase 1/2
Completion: Dec 31, 2012
NCT00954304
Duration of P-glycoprotein Inhibition After Oral Administration of HM30181AK Tablet
Start: Jun 30, 2009
Completion: Sep 30, 2009
NCT00998283
Assess the Safety, Tolerability, and Pharmacokinetic (PK) Characteristics of HM10460A (HNK460) in Healthy Adult Korean Subjects
Start: Oct 31, 2009
Completion: Sep 30, 2010
NCT01030315
A Study of HM10760A (Long-acting Erythropoietin) in Healthy Adult Caucasian and Japanese Subjects
Completion: Jan 31, 2011
NCT01013064
A Study of HM10760A (Long-acting Erythropoietin (EPO)) in Healthy Korean Subjects
Start: Nov 30, 2009
NCT01037543
Safety and PK of HM10460A (HNK460) in Healthy Adult Japanese and Caucasian Subjects
Completion: Apr 30, 2011
NCT01455571
Phase I Study to Determine the Maximum Tolerated Dose and to Assess the Safety and Pharmacokinetic Profile of HM781-36B in Patients With Advanced Solid Tumors
Completion: Jan 31, 2013
NCT01093729
A Study of HM11260C in Healthy Male Subject
Start: Feb 28, 2010
Completion: Oct 31, 2010
NCT01093742
A Study of HM10560A in Healthy Male Subject
Start: Mar 31, 2010
Completion: Aug 31, 2010
NCT01197001
A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and Losartan
Start: Aug 31, 2010
NCT01828359
The Efficacy and Safety Study of Anti-hypertension Combination Drug in Patients Uncontrolled With Monotherapy.
NCT01197014
Start: Sep 30, 2010
Completion: Dec 31, 2010
NCT01463982
Phase I of OratecanTM in Combination With Capecitabine in Patients With Advanced Solid Malignancies
Start: Dec 31, 2010
Completion: Dec 31, 2013
NCT01564875
Efficacy and Safety of Simvast Controlled Release (CR) and Zocor in Chronic Kidney Disease(CKD) Stage 3, 4 and 5 Patients With Hyperlipidemia
Completion: May 31, 2012
NCT01504581
Safety, Pharmacokinetic, Pharmacodynamic Study of LAPS-IFNa in Healthy Adult Subjects
Start: Mar 31, 2011
Completion: Not specified
NCT01282073
Mycophenolate Mofetil in Patients With Progressive Idiopathic Membranous Nephropathy
Role: Collaborator
Completion: May 31, 2016
NCT01442987
Efficacy and Safety of Irbesartan and Atorvastatin in Hypertension and Hyperlipidemia
Start: May 31, 2011
Completion: May 31, 2013
NCT01505777
Exploratory Clinical Study to Evaluate the Optimal Dosage of Mosapride and Probiotics in Irritable Bowel Syndrome Without Predominant Diarrhea
Completion: Jun 30, 2012
NCT01509209
Efficacy/Safety of Pseudoephedrine Plus Levocetirizine Versus Placebo in Patients With Vasomotor Rhinitis
Completion: Apr 30, 2013
NCT01455584
Clinical Trial to Determine the MTD of HM781-36B in Patients With Advanced Solid Tumors
Start: Jun 30, 2011
NCT01448330
A Bioequivalence Study Comparing Clopidogrel/Aspirin Combination Tablet With Coadministration of Clopidogrel and Aspirin
Start: Jul 31, 2011
Completion: Sep 30, 2011
NCT01447797
A Bioequivalence Study Comparing Irbesartan/Atorvastatin Combination Tablet With Coadministration of Irbesartan and Atorvastatin
Start: Sep 30, 2011
Completion: Dec 31, 2011
NCT01822340
Safety and Efficacy Study of Recombinant Human Growth Hormone in Adult Growth Hormone Deficiency Patients
Start: Oct 31, 2011
Completion: Feb 29, 2016
NCT01491503
A Drug Interaction Study of Montelukast and Levocetirizine
Start: Nov 30, 2011
Completion: Jan 31, 2012
NCT01509196
A Bioequivalence Study Comparing HIP0901 Capsule With Lipidilsupra Tablet
NCT01452451
Safety, Tolerability, Pharmacokinetics,Pharmacodynamics Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus
Start: Dec 31, 2011
NCT01514903
Pharmacokinetics of Sildenafil Following Administration of an Chewable Tablet of Sildenafil Relative to Viagra® Conventional Oral Tablet in Healthy Volunteers
NCT01521455
Therapeutic Equivalence Study of HCP0910 250/50 Mcg to Seretide 250 Diskus in Asthmatic Patients
Start: Feb 29, 2012
Completion: Jul 31, 2013
NCT01555398
Clinical Trial to Evaluate the Effect of Food on the Pharmacokinetic Characteristics of HIP0901 Capsule
NCT01573663
A Drug-Drug Interaction Study of Ambroxol and Levodropropizine
Completion: Apr 30, 2012
NCT01548157
Clinical Trial to Evaluate the Effect on the Pharmacokinetic Characteristics of HCP1007 Capsule
Start: Mar 31, 2012
NCT01588145
Phase I/II Trial to Evaluate Safety, Tolerability and Pharmacokinetic Profile of HM61713 in NSCLC Patients
Completion: Aug 31, 2017
NCT01640535
Efficacy and Safety of Concomitant Montelukast Sodium and Levocetirizine Dihydrochloride in Perennial Allergic Rhinitis (PAR) Patients
Start: Jun 30, 2012
Completion: Feb 28, 2013
NCT01651481
Study to Evaluate the Pharmacokinetics and Safety of Singulair and Xyzal in Free Combination and Fixed-dose Combination
Start: Jul 31, 2012
NCT01638286
Study to Evaluate a Pharmacokinetic Drug Interaction Between Eperisone Hydrochloride and Aceclofenac in Healthy Male Subjects
Phase: N/A
Start: Aug 31, 2012
NCT01688193
Study to Evaluate and Compare Safety and Pharmacokinetics of the HCP1004 and VIMOVO 500/20mg in Healthy Korean Male
Start: Oct 31, 2012
NCT01746771
A Phase I-II Study of HM781-36B Combined With Paclitaxel and Trastuzumab in HER-2 Positive Advanced Gastric Cancer
Start: Nov 30, 2012
Completion: Aug 31, 2015
NCT01724814
A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12460A
Start: Dec 20, 2012
Completion: Jul 1, 2014
NCT01764087
A Study of KX2-391 With Paclitaxel in Patients With Solid Tumors
Start: Dec 31, 2012
NCT01765478
Safety,PK/PD, Food Effect Study of Orally Administered HM71224 in Healthy Adult Male Volunteers
Start: Jan 31, 2013
Completion: Nov 30, 2014
NCT01775579
Evaluating a Pharmacokinetic Drug Interaction Between Metformin Hydrochloride and Rosuvastatin Calcium
Completion: Jun 30, 2013
NCT01718847
NOV120101 Phase 2 Study in NSCLC Patients With Aquired Resistance to 1st Generation EGFR Tyrosine Kinase Inhibitors
Completion: Sep 30, 2014
NCT01806818
Comparing Efficacy and Safety Between Eperisone a BID and a TID Regimen in Acute Low Back Pain Patients
Start: Feb 28, 2013
NCT01929070
A Pilot Study to Evaluate the Pharmacokinetics of Omega-3 Between Rosuvastatin and Omega-3 Coadministration and HCP1007
Completion: Mar 31, 2013
NCT01819428
NOV120101 (Poziotinib) for 1st Line Monotherapy in Patients With Lung Adenocarcinoma
Start: Mar 31, 2013
Completion: Nov 30, 2015
NCT01864863
To Compare the Pharmacokinetics of Traclear 62.5 mg Tablets and HGP1206 125mg 1 Tablet in Healthy Male Volunteers
Start: Apr 30, 2013
NCT01872182
Efficacy and Safety Study of ALS-L1023 in Patients With Abdominal Obesity of Metabolic Syndrome
Start: May 31, 2013
Completion: Jan 31, 2015
NCT01901757
Single-dose, 2-way Crossover Open Study to Evaluate the Food Effect on the PK of HCP1201 in Healthy Volunteers
Start: Jun 30, 2013
NCT01929512
Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 750mg and Rosuvastatin 20mg
Completion: Aug 31, 2013
NCT02057887
Safety,Tolerability and Pharmacokinetic Study of Recombinant Human Interferon Alfa 2B in Chronic Hepatitis C Patients (HM10660A)
Start: Jul 31, 2013
NCT01869985
Partial Replicated Crossover Clinical Study to Compare Pharmacokinectic Characteristics of Eperisone Hydrochloride and Aceclofenac With HCP1104 Treatment to Those of Co-administration of Eperisone Hydrochloride 50mg Tablet and Aceclofenac 100mg Tablet in Healthy Adult Male Volunteers
Start: Aug 31, 2013
Completion: Jan 31, 2014
NCT01894399
Study to Evaluate a Pharmacokinetic of HM61713 in Healthy Male Subjects
Start: Sep 30, 2013
Completion: Nov 30, 2013
NCT01913847
Safety and Efficacy Study of HGP1207 in Patients With Pulmonary Hypertension
Completion: Dec 31, 2018
NCT02011633
Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 500mg and Rosuvastatin 10mg
Start: Oct 31, 2013
NCT02026817
Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 750mg and Rosuvastatin 10mg
Start: Dec 31, 2013
NCT02059564
A Phase 1b Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus
Completion: Dec 31, 2014
NCT02057172
Glycaemic Control of Weekly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes
Start: Jan 31, 2014
NCT02075281
Effect of LAPS-Exendin on Body Weight in Obese Population
Start: Feb 28, 2014
Completion: Feb 28, 2015
NCT02081118
Glycaemic Control of Monthly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes
Completion: Apr 30, 2015
NCT02140489
Evaluating a Pharmacokinetic Drug Interaction Between Amlodipine/Losartan and Rosuvastatin
Completion: Aug 31, 2014
NCT02239484
Evaluating a Pharmacokinetic Drug Interaction Between Tadalafil and Tamsulosin
Start: Mar 31, 2014
NCT02127320
Investigating the Pharmacokinetic Drug Interactions Between Rosuvastatin and Ezetimibe
Start: Jun 30, 2014
NCT02205606
Efficacy/Safety of HCP1306 Tablet Versus HGP0816 Tablet in Patients With Primary Hypercholesterolemia
NCT02899455
Clinical Efficacy and Safety Evaluation of Co-administered HGP0904, HGP0608 and HGP0816 in Patients With Hypertension and Dyslipidemia
Start: Jul 31, 2014
Completion: Jun 30, 2016
NCT02387554
Pharmacokinetic Interaction Between HGP0904, HGP0608 and HGP1405
Start: Aug 31, 2014
Completion: Oct 31, 2014
NCT02294539
Comparison of Effects Between Amlodipine and Hydrochlorothiazide in Combination With Losartan on 24-hr Central Blood Pressure in Hypertensive Patients
Completion: May 18, 2016
NCT02243319
Investigating the Pharmacokinetic Drug Interactions Between HGP1201 and HGP0904
Start: Sep 30, 2014
NCT02552667
Efficacy and Safety of HCP1102 Capsule
Completion: Jul 31, 2015
NCT02587988
Trial to Evaluate the Efficacy and Safety of HCP1302
NCT02390882
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HGP0412 and HIP1402 in Patients With BPH
Start: Oct 31, 2014
NCT02551172
Evaluating the Efficacy and Safety of HCP1105 in Combined Hyperlipidemic Patients With High Risk for CHD
NCT02941848
Evaluate the Pharmacokinetics and Safety of HCP1306 and Co-administration of HGP0816, HGP1404 in Healthy Male Volunteers
Start: Nov 30, 2014
NCT02405065
Clinical Trial to Evaluate Safety, Tolerability and Pharmacokinetics and Anti-tumor Activity of HM95573
Start: Jan 12, 2015
Completion: May 16, 2018
NCT02302443
A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12470
Start: Jan 31, 2015
Completion: May 31, 2017
NCT02523547
Study to Evaluate the Non-inferiority of Cavir in HBeAg(+)Chronic Hepatitis B Patients Treated With Baraclude
Completion: Feb 28, 2017
NCT04039724
Pharmacokinetics of HCP1305 and Co-administration of HCP0605, HGP0816 in Healthy Male Volunteers
Start: Feb 28, 2015
Completion: May 31, 2015
NCT03330327
Molar Potency Study of HM12470 in Healthy Subjects
Start: Mar 30, 2015
Completion: Aug 17, 2017
NCT02444819
Phase II Trial to Evaluate the Efficacy and Safety of HM61713 as the 1st-line NSCLC Anticancer Therapy
Start: Mar 31, 2015
NCT02667938
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HCP1303 Capsules
NCT02418689
Poziotinib in Patients With HER2+ Recurrent Stage IV BC Who Have Received at Least 2 Prior HER2-directed Regimens
Start: Apr 30, 2015
Completion: Apr 30, 2021
NCT02473900
Evaluating the Bioequivalence of HIP1403, HGP0919
NCT02916602
A Study to Evaluate Efficacy and Safety of HCP1401 for Stage 2 Hypertension Patients Not Controlled by HCP0605
Completion: Sep 30, 2016
NCT02941731
Evaluating the Bioequivalence of HIP1403 and HGP0919 Suspensions
Completion: Sep 30, 2015
NCT03332849
Multiple Ascending Dose Study of HM12470 in Type 1 and Type 2 Diabetes Mellitus
Start: Jul 28, 2015
Completion: Apr 30, 2018
NCT02554136
Evaluating a Pharmacokinetic Drug Interaction Between HGP0918 and HGP0816
Start: Jul 31, 2015
NCT02712411
Pharmacokinetics and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 in Healthy Male Volunteers
NCT02485652
Phase II Trial of HM61713 for the Treatment of ≥2nd Line T790M Mutation Positive Adenocarcinoma of the Lung
Start: Aug 31, 2015
Completion: Dec 8, 2020
NCT02545829
Evaluating the Bioequivalence of HIP1302, HGP1406
Completion: Oct 31, 2015
NCT04252872
Pharmacokinetics of HCP1401 and Co-administration of HCP0605, HGP1405 in Healthy Male Volunteers
NCT02529800
Investigating the Pharmacokinetic Characteristics of HIP1402 in Healthy Male Volunteers
Start: Sep 30, 2015
NCT03110874
Clinical Trial on Education Method of Fluterol® Inhalation Inhaler for Asthma Control
Start: Oct 8, 2015
Completion: May 10, 2017
NCT02715401
PK and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 Under Fed Condition in Healthy Male Volunteers
Start: Oct 31, 2015
NCT04346862
Evaluation the Effect of Acetyl-L-carnitine in Patients With Mild Cognitive Impairment Accompanied With Chronic Cerebrovascular Disease
Start: Jan 26, 2016
Completion: Jun 30, 2020
NCT03212625
The Effect of Urea Cream on Sorafenib-associated Hand-Foot Skin Reaction
Start: Jan 28, 2016
Completion: Sep 20, 2018
NCT02940314
Safety and Pharmacokinetic Characteristics After Administration of HIP1503 and HGP1103 in Healthy Male Volunteers
Start: Mar 31, 2016
NCT04829149
Statin Monotherapy and Rosuzet Tab.(Rosuvastatin/Ezetimibe) Administration in Patients With Dyslipidemia in Korea
Start: Jun 14, 2016
Completion: Aug 29, 2019
NCT02941796
Pharmacokinetics and Safety of HCP1105 and Co-administration of HGP0918, HGP0816 in Healthy Male Volunteers
Start: Jun 30, 2016
Completion: Oct 31, 2016
NCT02943356
Effect of Tadalafil on Erectile Dysfunction Treatment and QOL Improvement Effect (by SF-12) in Andropause Patients With Erectile Dysfunction
Start: Jul 31, 2016
Completion: Jul 31, 2017
NCT02941679
Clinical Efficacy and Safety Evaluation of HCP1202 in COPD Patients
Start: Oct 31, 2016
NCT03089112
Pharmacokinetic Drug Interactions Between HGP1607 and HGP1501
Start: Mar 31, 2017
Completion: Jun 16, 2017
NCT03479073
Risk Factors of Stroke or Systemic Embolism After Atrial Fibrillation Ablation
Start: May 17, 2017
Completion: Jun 14, 2018
NCT03118817
Expansion Study to Evaluate the Efficacy and Safety of HM95573 in BRAF, KRAS or NRAS Mutant Solid Cancers
Start: May 19, 2017
Completion: Feb 4, 2020
NCT03284502
HM95573 in Combination With Either Cobimetinib or Cetuximab in Patients With Locally Advanced or Metastatic Solid Tumors
Start: May 22, 2017
Completion: Dec 31, 2024
NCT03228277
Olmutinib Trial in T790M (+) NSCLC Patients Detected by Liquid Biopsy Using BALF Extracellular Vesicular DNA
Start: Jul 17, 2017
Completion: Jul 31, 2019
NCT03371849
PK and Safety Study of HCP1102, HGP0813 and HGP1408
Start: Jul 19, 2017
Completion: Aug 3, 2017
NCT03330314
Molar Potency Study of HM12460A in Healthy Subjects
Start: Oct 24, 2017
Completion: Feb 8, 2018
NCT03332836
Multiple Ascending Dose Study of HM12460A in Type 2 Diabetes Mellitus
Start: Oct 25, 2017
Completion: Sep 30, 2020
NCT04788290
An Observational Study Assessing Effects in Patients With Combination Therapy With Raloxifene/Cholecalciferol
Start: Nov 6, 2017
Completion: Jul 13, 2020
NCT04654702
Observational Study to Evaluate Therapeutic Effectiveness and Safety of Monterizine Cap.
Start: Nov 17, 2017
Completion: Jul 20, 2020
NCT03353350
Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise
Start: Dec 5, 2017
Completion: Sep 7, 2020
NCT03372850
Safety, Pharmacokinetics and Pharmacodynamics of the Two Esomeprazole Formulations
Start: Feb 15, 2018
Completion: Jun 15, 2018
NCT05462535
An Observational Study to Evaluate Effectiveness and Safety of Amosartan Plus Tablet
Start: Feb 26, 2018
Completion: Jul 15, 2021
NCT03426722
L-carnitine vs Placebo for the Treatment of Muscle Cramps After Imatinib in Gastrointestinal Stromal Tumors
Start: Mar 1, 2018
Completion: Dec 24, 2019
NCT04510415
Olmutinib 600 mg QD in Patients With T790M-positive NSCLC After Treatment With an EGFR-TKI
Start: Mar 29, 2018
Completion: Dec 11, 2018
NCT03374241
A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM15211(Efocipegtrutide)
Start: Apr 4, 2018
Completion: Sep 14, 2018
NCT05450575
An Observational Study to Evaluate Effectiveness and Safety of Amosartan Q Tablet
Start: Apr 17, 2018
Completion: Jul 20, 2021
NCT03496298
Effect of Efpeglenatide on Cardiovascular Outcomes
Start: Apr 27, 2018
Completion: Dec 10, 2020
NCT04081844
A Study to Evaluate the Pharmacokinetic and Pharmacodynamic Interactions Between HGP0904, HGP0608, and HCP1306 in Healthy Male Subjects.
Start: May 3, 2018
Completion: Jun 28, 2018
NCT03684642
Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
Start: Sep 26, 2018
Completion: Nov 17, 2020
NCT04032782
A First-in-Human, Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HM15136(Efpegerglucagon) in Healthy Subjects
Start: Oct 2, 2018
NCT03666351
Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV Disease
Start: Oct 18, 2018
Completion: Jul 25, 2022
NCT04087525
A Study to Evaluate the Pharmacokinetics and Safety of HIP1701 in Healthy Subjects
Start: Oct 23, 2018
Completion: Nov 27, 2018
NCT04324918
Efficacy and Safety of HCP1102 Capsule in Patients With Perennial Allergic Rhinitis
Completion: Jun 24, 2019
NCT04080726
Efficacy and Safety of HIP1601 Capsule
Start: Oct 25, 2018
Completion: Dec 3, 2019
NCT03744182
A Study of Multiple Doses of HM15211(Efocipegtrutide) in Obese Subjects With NAFLD
Start: Nov 1, 2018
Completion: Mar 18, 2020
NCT04252963
Clinical Trial to Assess the Efficacy and Safety of MUCOLASE Tablet(Streptokinase • Streptodornase)
Start: Nov 2, 2018
Completion: May 31, 2021
NCT03713684
Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Alone or in Combination With Oral Antidiabetic Drug(s)
Start: Nov 9, 2018
Completion: Jan 4, 2021
NCT04084197
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HIP1801 in Healthy Male Subjects.
Start: Dec 19, 2018
Completion: Jan 4, 2019
NCT04322266
A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination and Co-Administration of HGP0904, HGP0608 and HCP1306 Tablets in Healthy Male Subjects.
Start: Dec 21, 2018
Completion: Feb 13, 2019
NCT03826641
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1801 in Healthy Subjects
Start: Feb 1, 2019
Completion: Apr 16, 2019
NCT04084184
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HGP1602 in Healthy Subjects
Start: Mar 15, 2019
Completion: Mar 29, 2019
NCT03897868
A Phase 2 Study to Assess Dose-response Relationship of HCP1803 in Patients With Essential Hypertension
Start: Mar 21, 2019
Completion: Feb 26, 2020
NCT03882112
Food-effect on PK and PD of Single Oral Dose of HIP1601 in Healthy Male Subjects
Start: Apr 17, 2019
Completion: Aug 28, 2019
NCT05487560
An Observational Study to Evaluate the Incidence of MACCE According to Time Interval of Taking Medication in Patients With Acute Coronary Syndrome or Cerebral Infarction Who Received DAPT for the Secondary Prevention and Esomezol Cap for the Prevention of Gastrointestinal Bleeding
Start: Apr 18, 2019
Completion: Jun 22, 2022
NCT04081857
A Study to Evaluate the Pharmacokinetics and Safety of HCP1704 in Healthy Subjects
Start: Jun 3, 2019
Completion: Aug 5, 2019
NCT04325620
Safety to Evaluate the Efficacy and Safety of HIP1601 in Patients With Non Erosive Reflux Disease
Start: Jun 10, 2019
Completion: Aug 3, 2020
NCT05422677
An Observational Study of Tamsulosin in Patients With Benign Prostatic Hyperplasia
Start: Jul 15, 2019
Completion: Aug 24, 2021
NCT04074551
A Phase 3 Study to Compare the Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and Dyslipidemia
Start: Jul 16, 2019
Completion: Mar 17, 2020
NCT04044170
Poziotinib in Patients With NSCLC Having EGFR or HER2 Exon 20 Insertion Mutation
Start: Jul 30, 2019
Completion: Apr 13, 2020
NCT03770728
Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Alone or in Combination With Sulfonylurea
Start: Aug 1, 2019
Completion: Dec 27, 2020
NCT04167553
Study for Multiple Doses of HM15136(Efpegerglucagon) in Obese or Overweight Subjects With Comorbidities
Start: Aug 30, 2019
Completion: Dec 9, 2020
NCT04076293
Single Ascending Dose Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM15912(Sonefpeglutide) in Healthy Korean Subjects
Start: Oct 8, 2019
Completion: May 3, 2021
NCT04204629
Food-effect on PK and PD of Single Oral Dose of HIP1601 in Healthy Subjects
Start: Jan 13, 2020
Completion: Feb 20, 2020
NCT05555238
An Observational Study to Evaluate the Treatment of Newvast® Tab(Atorvastatin) in Korean Patients With Dyslipidemia
Start: Jan 16, 2020
Completion: Jan 27, 2022
NCT04324905
Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of HIP1802 to HGP1705 in Healthy Volunteers
Start: Apr 29, 2020
Completion: Oct 30, 2020
NCT04652349
Efficacy and Safety of HGP1910 and HCP1903 in Patients With Primary Hypercholesterolemia
Start: Jul 6, 2020
Completion: Jan 14, 2021
NCT04505436
Study to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide) in Subjects
Start: Jul 31, 2020
Completion: Jul 27, 2026
NCT04820907
Clinical Efficacy and Safety Evaluation of HCP1904-1 in Essential Hypertension Patients
Start: Oct 27, 2020
Completion: Sep 30, 2021
NCT04830449
Clinical Efficacy and Safety Evaluation of HCP1904-2 in Essential Hypertension Patients
Start: Oct 29, 2020
NCT04762407
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1903
Start: Nov 20, 2020
Completion: Feb 24, 2021
NCT04764201
The Pharmacokinetic Characteristics and Safety Between HIP2001 and HGP2001 in Healthy Volunteers
Start: Jan 16, 2021
Completion: Mar 8, 2021
NCT04959305
A Phase 2 Study to Explore the Dose of HCP1803 in Patients With Essential Hypertension
Start: Apr 22, 2021
Completion: Feb 28, 2022
NCT04967014
Study to Evaluate the Safety and Pharmacodynamic/Pharmacokinetic Characteristics of HIP2101 in Healthy Volunteers
Start: May 6, 2021
Completion: Jun 18, 2021
NCT04768686
FLX475 Combined With Pembrolizumab in Patients With Advanced or Metastatic Gastric Cancer
Start: May 18, 2021
Completion: Aug 12, 2024
NCT04946903
A Study to Evaluate the Pharmacokinetics and Safety Between HCP1902 and Co-administration of RLD2007, RLD2008
Start: Jun 10, 2021
Completion: Aug 10, 2021
NCT04975711
Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of HIP2105 to RLD2104 in Healthy Volunteers
Start: Jul 12, 2021
Completion: Nov 3, 2021
NCT05191563
A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination of HCP1904 and Co-Administration of RLD2001-2 and RLD2006 Tablets in Healthy Subjects.
Start: Jul 31, 2021
Completion: Sep 12, 2021
NCT05024721
Study to Evaluate the Efficacy and Safety of HIP2101 in Patients With Acute or Chronic Gastritis
Start: Aug 9, 2021
Completion: Mar 7, 2022
NCT05155995
A Study to Evaluate the Pharmacokinetics and Safety Between HCP2001 and Co-administration of Each Component in Healthy Volunteers
Start: Sep 28, 2021
Completion: Nov 27, 2022
NCT04167813
Trial of Ondansetron as a Parkinson's HAllucinations Treatment
Start: Oct 1, 2021
Completion: Aug 30, 2024
NCT05199129
Clinical Efficacy and Safety Evaluation of HCP1904-3 in Essential Hypertension Patients
Start: Nov 17, 2021
Completion: Sep 14, 2022
NCT04775706
Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects
Start: Mar 3, 2022
Completion: May 31, 2028
NCT04732416
HM15136 (Efpegerglucagon) Treatment for 8 Weeks in Subjects Aged ≥2 Years With Congenital Hyperinsulinism (CHI)
Start: May 5, 2022
Completion: Dec 31, 2025
NCT05362110
A Study to Evaluate Efficacy and Safety of HCP1803 in Patients With Essential Hypertension
Start: May 16, 2022
Completion: Jun 5, 2023
NCT05407220
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1904 in Healthy Male Volunteers.
Start: Jun 29, 2022
NCT05481307
A Study to Evaluate Pharmacokinetic/Pharmacodynamic Drug-drug Interaction and Safety/Tolerability Between RLD2202 and RLD2203
Start: Aug 2, 2022
Completion: Oct 25, 2022
NCT05450601
A Study to Evaluate the Efficacy and Safety of HCP2102 in Essential Hypertension Patients
Start: Sep 1, 2022
Completion: Dec 11, 2023
NCT05548387
A Study to Evaluate the Pharmacokinetics and Safety Between HCP2202 and Co-administration of Each Component in Healthy Volunteers
Start: Sep 2, 2022
Completion: Nov 10, 2022
NCT05548543
A Study to Evaluate the Pharmacokinetics and Safety Between HCP2202 and Co-administration of Each Component in Healthy Volunteers Under Fed Conditions
Start: Oct 17, 2022
Completion: Dec 22, 2022
NCT05711381
Phase 1 Study of PK and Safety of HM15912 (Sonefpeglutide) in Subjects With Normal and Severe Kidney Function
Start: Dec 2, 2022
Completion: Aug 15, 2023
NCT05598151
Dose Escalation and Expansion Study of HM97662 in Advanced or Metastatic Solid Tumors
Start: Jan 11, 2023
Completion: Jun 30, 2028
NCT05723549
A Study to Evaluate the PK, Safety and Tolerability of HCP1803.
Start: Feb 2, 2023
Completion: Mar 20, 2023
NCT05656092
A Study to Evaluate the Effiacy and Safety of HIP0612 in Patients With Gastric Ulcer
Start: Mar 6, 2023
Completion: Dec 19, 2024
NCT05737082
A Study to Evaluate the Pharmacokinetics and Safety Between HCP2201 and Co-administration of Each Component in Healty Male Volunteers
Start: Mar 30, 2023
Completion: May 14, 2023
NCT05862090
A Study to Evaluate the Drug-drug Interaction and Safety of RLD2301 and RLD2007 in Healthy Volunteers
Start: Apr 5, 2023
Completion: May 26, 2023
NCT05949333
Reducing Neutropenia Incidence With Pegfilgrastim Administration on Day 3 After Chemotherapy
Start: Nov 7, 2023
Completion: Jul 31, 2025
NCT06234397
Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or Metastatic Solid Tumors
Start: Dec 28, 2023
Completion: Jan 31, 2028
NCT06174779
A Study to Evaluate Efficacy and Safety of HM11260C in Adult Obesity Patients Without Diabetes Mellitus
Start: Jan 3, 2024
Completion: Jul 31, 2026
NCT06438172
A Study to Evaluate Efficacy and Safety of HCP1803 Compared to RLD2001-1 in Patients with Essential Hypertension
Start: Mar 25, 2024
Completion: Dec 2, 2024
NCT06346184
A Study to Evaluate the Pharmacokinetics and Safety Between HCP2303 and Co-administration of Each Component in Healthy Volunteers
Start: May 2, 2024
Completion: Jun 10, 2024
NCT06174766
A Study to Evaluate Efficacy and Safety of HGP2102 in Essential Hypertension Patients
Start: May 10, 2024
Completion: Dec 31, 2026
NCT06357910
A Study to Evaluate the Pharmacokinetics and Safety Between HCP2303 and Co-administration of Each Component in Healthy Volunteers Under Fed Conditions
Start: May 17, 2024
Completion: Jul 1, 2024
NCT06481098
A Phase 1 Study to Assess HM15275 in Healthy and Obese Subjects.
Start: May 28, 2024
Completion: May 2, 2025
NCT06518122
A Study to Evaluate the Drug-drug Interaction and Safety Between HCP1306, RLD2302 and RLD2102 in Healthy Volunteers
Start: Sep 1, 2024
Completion: Jan 3, 2025
NCT06595004
A Study to Evaluate the Efficacy and Safety of HCP1004 in Chronic Low-Back Pain Patients
Start: Nov 20, 2024
Completion: Jun 30, 2025
NCT06724016
Dose Escalation and Expansion Study of HM16390 in Advanced or Metastatic Solid Tumors
Start: Dec 11, 2024
Completion: Mar 31, 2030
NCT06858397
A proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Disease
Start: May 14, 2025
Completion: Aug 30, 2028
NCT07205900
A Phase 2 Study to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes Mellitus
Start: Oct 31, 2025
Completion: Jan 31, 2027
NCT07219589
A SAD Study of HM17321 in Healthy Adult Participants
Start: Dec 31, 2025
Completion: May 31, 2026